Department of Justice
2 records
DOJ: AstraZeneca and Cephalon to Pay $46.5 Million and $7.5 Million, Respectively, for Allegedly Underpaying Rebates Owed Under Medicaid Drug Rebate Progra
2015-07-06
AstraZeneca LP has agreed to pay the United States and participating states a total of $46.5 million, plus interest, to resolve allegations that it knowingly underpaid rebates owed under the Medicaid ...
View Source
DOJ: AstraZeneca to Pay $7.9 Million to Resolve Kickback Allegations
2015-02-11
AstraZeneca LP, a pharmaceutical manufacturer based in Delaware, has agreed to pay the government $7.9 million to settle allegations that it engaged in a kickback scheme in violation of the False Clai...
View Source
EPA (Environmental Protection Agency)
1 records
epa_echo
2 records
fda
2 records
FDA Drug Recall: PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspen
2013-03-20
Class III — Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.
View Source
FDA Drug Recall: PULMICORT RESPULES 0.25 mg/2 ml Budesonide Inhalation Suspension (30 ampules/
2013-03-20
Class III — Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.
View Source
ftc_enforcement
1 records
Novartis AG / AstraZeneca PLC
2000-11-01
FTC merger enforcement action FY2001 matter 10082; matched respondent 'AstraZeneca PLC'
View Source
lobbying
3 records
nppes
1 records
ny_corps
1 records
NY Corp: ASTRAZENECA LP
1998-08-19
FOREIGN LIMITED PARTNERSHIP | County: New York | Jurisdiction: Delaware
View Source
SEC EDGAR
1 records
Be informed when major changes happen on C.F.A.I. — new data sources, platform updates, critical enforcement alerts
No spam. Only major updates. Unsubscribe anytime.